M. Uhart

Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe

M. Uhart, Hélène Bricout, E. Clay et al. · Human Vaccines & Immunotherapeutics · 2016 · 58 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy

Francesco Saverio Mennini, Paolo Bonanni, F. Bianic et al. · Cost Effectiveness and Resource Allocation · 2017 · 53 citations · Full text

Veterinary Medicine, Oncology, Preventive Medicine +17

Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria

Louis Boiron, Elmar A. Joura, Nathalie Largeron et al. · BMC Infectious Diseases · 2016 · 46 citations · Full text

Medicine, Pharmacoeconomics, Preventive Medicine +17

An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany

Nathalie Largeron, Karl Ulrich Petry, Jorge Jacob et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2016 · 44 citations

Veterinary Medicine, Pharmacoeconomics, Preventive Medicine +17

Estimating the burden of influenza‐related and associated hospitalizations and deaths in France: An eight‐season data study, 2010–2018

Magali Lemaître, Fayssoil Fouad, Fabrice Carrat et al. · Influenza and Other Respiratory Viruses · 2022 · 36 citations · Full text

Public Health, Infectious Diseases, Population Health Sciences +14